Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Small Interfering | 8 | 2025 | 921 | 0.780 |
Why?
|
| Histidine Kinase | 1 | 2021 | 3 | 0.710 |
Why?
|
| Carbon | 1 | 2021 | 52 | 0.680 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2021 | 164 | 0.630 |
Why?
|
| Oligonucleotides | 3 | 2025 | 221 | 0.380 |
Why?
|
| Ribose | 1 | 2025 | 5 | 0.240 |
Why?
|
| RNA Interference | 2 | 2025 | 618 | 0.210 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2023 | 18 | 0.210 |
Why?
|
| Dystrophin | 1 | 2023 | 31 | 0.210 |
Why?
|
| MutS Homolog 3 Protein | 1 | 2023 | 4 | 0.210 |
Why?
|
| Nucleic Acids | 1 | 2024 | 60 | 0.200 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2023 | 32 | 0.200 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2023 | 41 | 0.200 |
Why?
|
| Mice | 7 | 2024 | 10844 | 0.190 |
Why?
|
| Central Nervous System | 1 | 2024 | 197 | 0.190 |
Why?
|
| Huntington Disease | 1 | 2023 | 154 | 0.180 |
Why?
|
| Second Messenger Systems | 1 | 2021 | 27 | 0.180 |
Why?
|
| Vitiligo | 1 | 2023 | 121 | 0.170 |
Why?
|
| Myostatin | 1 | 2020 | 14 | 0.170 |
Why?
|
| Mycobacterium | 1 | 2021 | 37 | 0.170 |
Why?
|
| Molecular Docking Simulation | 1 | 2021 | 79 | 0.170 |
Why?
|
| Mycobacterium smegmatis | 1 | 2021 | 67 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2023 | 324 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2020 | 200 | 0.160 |
Why?
|
| RNA, Messenger | 1 | 2025 | 1537 | 0.150 |
Why?
|
| Gene Transfer Techniques | 1 | 2020 | 321 | 0.140 |
Why?
|
| Animals | 7 | 2024 | 20663 | 0.140 |
Why?
|
| Bacteria | 1 | 2021 | 306 | 0.140 |
Why?
|
| Lung | 1 | 2023 | 956 | 0.140 |
Why?
|
| Bacterial Proteins | 1 | 2021 | 768 | 0.120 |
Why?
|
| RNA, Double-Stranded | 2 | 2023 | 112 | 0.100 |
Why?
|
| Humans | 8 | 2025 | 63445 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2021 | 3035 | 0.090 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2025 | 37 | 0.060 |
Why?
|
| alpha-Synuclein | 1 | 2025 | 35 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2025 | 77 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2025 | 257 | 0.060 |
Why?
|
| RNA Stability | 1 | 2025 | 102 | 0.060 |
Why?
|
| Antagomirs | 1 | 2024 | 5 | 0.060 |
Why?
|
| Acetylgalactosamine | 1 | 2024 | 10 | 0.050 |
Why?
|
| tau Proteins | 1 | 2025 | 201 | 0.050 |
Why?
|
| Mice, Inbred mdx | 1 | 2023 | 15 | 0.050 |
Why?
|
| Janus Kinase 1 | 1 | 2023 | 11 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2024 | 109 | 0.050 |
Why?
|
| Neostriatum | 1 | 2023 | 26 | 0.050 |
Why?
|
| Exons | 1 | 2023 | 199 | 0.050 |
Why?
|
| Corpus Striatum | 1 | 2023 | 97 | 0.050 |
Why?
|
| Huntingtin Protein | 1 | 2023 | 143 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2023 | 144 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2023 | 238 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2024 | 400 | 0.040 |
Why?
|
| Muscular Diseases | 1 | 2020 | 50 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 423 | 0.040 |
Why?
|
| Liver | 1 | 2024 | 855 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 677 | 0.040 |
Why?
|
| Myocardium | 1 | 2020 | 279 | 0.040 |
Why?
|
| Heart | 1 | 2020 | 283 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2020 | 218 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2024 | 687 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 3396 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2023 | 791 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 741 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 2187 | 0.030 |
Why?
|
| Male | 2 | 2024 | 29891 | 0.020 |
Why?
|